Efficacy of Nanofiber Sheets Incorporating Lenvatinib in a Hepatocellular Carcinoma Xenograft Model - Yoshida, Terufumi; Kaibori, Masaki; Fujisawa, Nanami; Ishizuka, Mariko; Sumiyama, Fusao; Hatta, Masahiko; Kosaka, Hisashi; Matsui, Kosuke; Suzuki, Kensuke; Akama, Tomoya O.; Katano, Tayo; Yoshii, Kengo; et al. (Nanomaterials (Basel, Switzerland), 2022)
Keywords: Animals; Antibodies; Anticancer properties; Antitumor activity; Body weight; Cancer therapies; Controlled release; Drug delivery; drug delivery system; Drug delivery systems; Drug dosages; electrospun nanofiber sheet; FDA approval; Hepatitis; Hepatocellular carcinoma; HuH-7; lenvatinib; Liver cancer; Nanofibers; Oral administration; poly ε-caprolactone; Polycaprolactone; Prolongation; Sheets; Signal transduction; Survival; Sustained release; Tumors; Vascular endothelial growth factor; Xenografts; Xenotransplantation; United States--US; Japan; HuH-7; electrospun nanofiber sheet; drug delivery system; lenvatinib; poly ε-caprolactone